Flexion Therapeutics (FLXN) PT Raised to $21 at Laidlaw

May 9, 2019 6:49 AM EDT Send to a Friend

Laidlaw analyst Francois Brisebois raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Flexion Therapeutics (FLXN) PT Raised to $21 at Laidlaw

Member Login

Free News Feed